Exelixis (EXEL) Total Debt Growth (1y) (2011 - 2017)
Exelixis (EXEL) Total Debt Growth (1y) (2011 - 2017) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Total Debt Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
5.94% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Exelixis |
13.37 Bn |
12.59 Bn |
590.86 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2017 |
5.44% |
| Dec 30, 2016 |
36.40% |
| Sep 30, 2016 |
-63.50% |
| Jun 30, 2016 |
-65.63% |
| Mar 31, 2016 |
28.11% |
| Dec 31, 2015 |
-54.92% |
| Sep 30, 2015 |
-54.42% |
| Jun 30, 2015 |
-54.09% |
| Mar 31, 2015 |
4.60% |
| Dec 31, 2014 |
96.45% |
| Sep 30, 2014 |
94.47% |
| Jun 30, 2014 |
91.22% |
| Mar 31, 2014 |
-12.44% |
| Dec 31, 2013 |
-1.91% |
| Sep 30, 2013 |
-2.29% |
| Jun 30, 2013 |
-2.72% |
| Mar 31, 2013 |
-3.03% |
| Dec 31, 2012 |
8.01% |
| Sep 30, 2012 |
-19.01% |
| Jun 30, 2012 |
-18.88% |
